John Houston
Vermogen: 9 M $ op 31-05-2026
Vermogen: 9 M $ op 31-05-2026
John G. Houston bekleedt de functie van President, Chief Executive Officer & Director bij Arvinas, Inc. en President, Chief Executive Officer & Director bij Arvinas Operations, Inc. (een dochteronderneming van Arvinas, Inc.). Hij zit ook in de raad van bestuur van NextCure, Inc., Cybrexa, Inc. en Oerth Bio LLC. John G. Houston bekleedde voorheen de functie van Senior Vice President-Specialty Discovery bij Bristol Myers Squibb Co. en Head-Lead Discovery Unit bij GlaxoSmithKline Research & Development Ltd. Hij behaalde een doctoraat aan de Universiteit van Glasgow en een doctoraat aan de Heriot-Watt Universiteit.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ARVINAS, INC. 1,54% | 31-03-2026 | 992.689 ( 1,54% ) | 9 M $ | 31-05-2026 |
NEXTCURE, INC. -.--% | 22-04-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ARVINAS, INC. | Directeur/Bestuurslid | 12-02-2026 |
| NEXTCURE, INC. | Directeur/Bestuurslid | 10-09-2020 |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Algemeen Directeur | 21-09-2017 |
Cybrexa, Inc.
Cybrexa, Inc. BiotechnologyHealth Technology Develops molecule DNA repair inhibitors that directly target the tumor microenvironment | Directeur/Bestuurslid | 03-09-2019 |
Oerth Bio LLC
Oerth Bio LLC BiotechnologyHealth Technology Develops biotechnology products | Directeur/Bestuurslid | 01-06-2019 |
Connecticut United for Research Excellence, Inc.
Connecticut United for Research Excellence, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services for biomedical research and biotechnology to advance and support research and technology | Directeur/Bestuurslid | 01-12-2015 |
Bioct Innovation Commons | Directeur/Bestuurslid | 01-12-2015 |
| Bedrijven | Functie | Einde |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-08-2016 |
GlaxoSmithKline Research & Development Ltd.
GlaxoSmithKline Research & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Functions as a commercial physical research company | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 11 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heriot-Watt University
Heriot-Watt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Connecticut United for Research Excellence, Inc.
Connecticut United for Research Excellence, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services for biomedical research and biotechnology to advance and support research and technology | Commercial Services |
GlaxoSmithKline Research & Development Ltd.
GlaxoSmithKline Research & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Functions as a commercial physical research company | Commercial Services |
Arvinas, Inc.
Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
NextCure, Inc.
NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
Cybrexa, Inc.
Cybrexa, Inc. BiotechnologyHealth Technology Develops molecule DNA repair inhibitors that directly target the tumor microenvironment | Health Technology |
Oerth Bio LLC
Oerth Bio LLC BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Bioct Innovation Commons | Finance |
Kies jouw editie
Alle financiële informatie op nationaal niveau